FDA
approval
· 2012-03-01
FDA Approved: VIOKACE — Original Application (Aimmune Therapeutics, Inc.)
Summary
FDA approved Viokace (pancrelipase) via an original application from Aimmune Therapeutics, establishing a pancrelipase therapy for exocrine pancreatic insuffici…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for VIOKACE (PANCRELIPASE)